Table of Contents
PHILADELPHIA– Rite Aid recently announced that appointments are now available for eligible customers ages 65 and older seeking an additional dose of the updated COVID-19 (2023-2024) vaccines at its locations, including Bartell Drugs locations in the Pacific Northwest. The latest ACIP and CDC recommendation aims to increase vaccine protection that may have lessened in vulnerable adults.
“As COVID-19 continues to impact communities across our footprint, it is important for customers to stay current on vaccinations to protect themselves and remain healthy,” said Karen Staniforth, Senior Vice President and Chief Pharmacy Officer at Rite Aid. “Rite Aid wants to ensure our customers safeguard their health, especially those in vulnerable populations, including our customers ages 65 and older.”
The updated COVID-19 vaccine provides enhanced protection against currently circulating variants of COVID-19. According to the new recommendation, all customers ages 65 and older who previously received the COVID-19 vaccine (2023-2024) should receive an additional dose four months after receipt of the prior dose. Customers who have not received the COVID-19 vaccine (2023-2024) should protect themselves against the virus by getting vaccinated. The COVID-19 vaccine (2023-2024) can be co-administered with other vaccinations.
Eligible Rite Aid customers may schedule an appointment at www.riteaid.com/pharmacy/scheduler. Bartell Drugs customers can use the online scheduling tool linked here. Additionally, walk-ins are welcome. Select Rite Aid and Bartell Drugs locations are now Immunization Centers and have dedicated immunization staff present Monday through Friday during peak customer vaccination times for either scheduled appointments or walk ins. Immunization Center stores provide vaccinations and vaccination consultations to meet the demands of a higher volume of customers per day. Rite Aid pharmacists are trained to immunize customers ages three and older based on the CDC’s vaccine guidelines and state regulations.
